BIOMAT Database Logo BIOMAT Database Logo

Human C5a anaphylatoxin: gene cloning and expression in Escherichia coli. 1992

W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
Institut für Medizinische Mikrobiologie, Medizinische Hochschule Hannover, Germany.

A gene coding for the human anaphylatoxin C5a was cloned and expressed in Escherichia coli. A combination of reverse transcription of mRNA of the U937 cell line with subsequent preparative polymerase chain reaction was employed to obtain the gene. The sequence was cloned into the plasmid vector pKK 233-2 behind an ATG initiation codon under the control of a trc promotor. After purification by ion exchange chromatography and reversed phase FPLC a mixture of predominantly non-glycosylated recombinant human C5a with a beta-mercaptoethanol adduct at cysteine 27 and the N-methionyl derivative was obtained which was homogeneous on silver-stained gels, immunoreactive with C5a-specific monoclonal antibodies and functionally active in releasing myeloperoxidase from human granulocytes and ATP from guinea pig platelets. The final yield was about 0.4-0.8 mg purified recombinant C5a per liter bacterial culture.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014169 Transformation, Bacterial The heritable modification of the properties of a competent bacterium by naked DNA from another source. The uptake of naked DNA is a naturally occuring phenomenon in some bacteria. It is often used as a GENE TRANSFER TECHNIQUE. Bacterial Transformation

Related Publications

W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
Human C5a anaphylatoxin: gene synthesis, expression, and recovery of biologically active material from Escherichia coli.
January 1988, Methods in enzymology,
W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
[Chemico-enzymatic synthesis, cloning and expression of a gene for an analog of human anaphylatoxin C5a].
May 1995, Bioorganicheskaia khimiia,
W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
Cloning of the Human C5a Anaphylatoxin Receptor, and More.
January 2015, Frontiers in immunology,
W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
High-level C5a gene expression and recovery of recombinant human C5a from Escherichia coli.
August 1987, Agents and actions,
W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
cDNA cloning and characterization of rat C5a anaphylatoxin receptor.
January 1997, Microbiology and immunology,
W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
Cloning and expression of the streptococcal C5a peptidase gene in Escherichia coli: linkage to the type 12 M protein gene.
June 1989, Infection and immunity,
W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
[Cloning of Human beta2-microglobulin gene and efficient expression in Escherichia coli].
June 2006, Zhongguo shi yan xue ye xue za zhi,
W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
Cloning and expression of human beta-defensin-2 gene in Escherichia coli.
February 2002, Protein and peptide letters,
W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
[Cloning and expression of TPS1 gene in Escherichia coli].
January 2001, Yi chuan xue bao = Acta genetica Sinica,
W Bautsch, and M Emde, and T Kretzschmar, and J Köhl, and D Suckau, and D Bitter-Suermann
High-level expression of a gene encoding the human complement factor C5a in Escherichia coli.
January 1986, Gene,
Copied contents to your clipboard!